Skip to content
Pharma Observatory a Scientist.com platform

Clinical trial

A Study on Evaluating the Consistency of CASIA2, Pentacam, and Corvis ST Measurement Parameters and the Diagnostic Efficacy of Early Keratoconus

NCT06152484 is registered in ClinicalTrials.gov with Tianjin Eye Hospital as lead sponsor.

NCT NCT06152484
Email me this page as a PDF

Search trials, sites, companies and investigators, and follow each one to the others. Individual plan, $249/seat/mo. Card required.

Get the NCT06152484 report as a PDF

The PDF carries up to 50 rows of each section, where the page shows the first few, with the sources listed. Enter a work email and confirm it from the message we send, and the report follows by email.

Registry record

As filed in ClinicalTrials.gov.

Title
A Study on Evaluating the Consistency of CASIA2, Pentacam, and Corvis ST Measurement Parameters and the Diagnostic Efficacy of Early Keratoconus
Lead sponsor
Tianjin Eye Hospital
Phase
Observational
Overall status
Unknown status
Start date
July 1, 2023
Completion date
April 1, 2024
Enrollment
200 (estimated)
Sites
1

Conditions

As the registry lists them; a condition with its own page is linked.

scansys, pentacam, keratoconus, subclinical keratoconus